ADAMTS4 AS A BLOOD BIOMARKER AND THERAPEUTIC TARGET FOR CHRONIS RENAL FAILURE
摘要
ADAMTS4 is found to be useful as a blood biomarker for chronic renal failure and also as a therapeutic target for treating chronic renal failure in a human individual. A change in the level of expression of selected genes as disclosed herein in kidney tissue of an individual may also be used to diagnose chronic renal failure in an individual.